These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22106196)

  • 1. An open-label, three-arm pilot study of the safety and efficacy of topical Microcyn Rx wound care versus oral levofloxacin versus combined therapy for mild diabetic foot infections.
    Landsman A; Blume PA; Jordan DA; Vayser D; Gutierrez A
    J Am Podiatr Med Assoc; 2011; 101(6):484-96. PubMed ID: 22106196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical application of a gentamicin-collagen sponge combined with systemic antibiotic therapy for the treatment of diabetic foot infections of moderate severity: a randomized, controlled, multicenter clinical trial.
    Lipsky BA; Kuss M; Edmonds M; Reyzelman A; Sigal F
    J Am Podiatr Med Assoc; 2012; 102(3):223-32. PubMed ID: 22659765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.
    Lipsky BA; Holroyd KJ; Zasloff M
    Clin Infect Dis; 2008 Dec; 47(12):1537-45. PubMed ID: 18990064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of superoxidized aqueous solution versus saline as a replacement solution in the versajet lavage system in chronic diabetic foot ulcers: a pilot study.
    Bowling FL; Crews RT; Salgami E; Armstrong DG; Boulton AJ
    J Am Podiatr Med Assoc; 2011; 101(2):124-6. PubMed ID: 21406695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
    West M; Boulanger BR; Fogarty C; Tennenberg A; Wiesinger B; Oross M; Wu SC; Fowler C; Morgan N; Kahn JB
    Clin Ther; 2003 Feb; 25(2):485-506. PubMed ID: 12749509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors.
    Leroy O; Saux P; Bédos JP; Caulin E
    Chest; 2005 Jul; 128(1):172-83. PubMed ID: 16002932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
    Harkless L; Boghossian J; Pollak R; Caputo W; Dana A; Gray S; Wu D
    Surg Infect (Larchmt); 2005; 6(1):27-40. PubMed ID: 15865549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
    Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
    Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
    Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
    Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and safety of moxifloxacin versus levofloxacin plus metronidazole for community-acquired pneumonia with aspiration factors.
    Sun T; Sun L; Wang R; Ren X; Sui DJ; Pu C; Ren Y; Liu Y; Yang Z; Li F
    Chin Med J (Engl); 2014; 127(7):1201-5. PubMed ID: 24709166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study.
    Ennis WJ; Foremann P; Mozen N; Massey J; Conner-Kerr T; Meneses P
    Ostomy Wound Manage; 2005 Aug; 51(8):24-39. PubMed ID: 16234574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
    Paglia M; Peterson J; Fisher AC; Qin Z; Nicholson SC; Kahn JB
    Curr Med Res Opin; 2010 Jun; 26(6):1433-41. PubMed ID: 20394471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis.
    Naber KG; Llorens L; Kaniga K; Kotey P; Hedrich D; Redman R
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3782-92. PubMed ID: 19581455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dakin's solution in the treatment of severe diabetic foot infections.
    Duarte B; Formiga A; Neves J
    Int Wound J; 2020 Apr; 17(2):277-284. PubMed ID: 31721437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue and serum levofloxacin concentrations in diabetic foot infection patients.
    Oberdorfer K; Swoboda S; Hamann A; Baertsch U; Kusterer K; Born B; Hoppe-Tichy T; Geiss HK; von Baum H
    J Antimicrob Chemother; 2004 Oct; 54(4):836-9. PubMed ID: 15375105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial.
    Cantor LB; WuDunn D; Yung CW; Valluri S; Catoira YP; Hoop JS; Morgan LS
    Br J Ophthalmol; 2008 Mar; 92(3):345-7. PubMed ID: 18211932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
    Cornely OA; Wicke T; Seifert H; Bethe U; Schwonzen M; Reichert D; Ullmann AJ; Karthaus M; Breuer K; Salzberger B; Diehl V; Fätkenheuer G
    Int J Hematol; 2004 Jan; 79(1):74-8. PubMed ID: 14979482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M; de Freitas F; Winter M
    Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.